EUVIMEDDescoperă EUVIMED
Open access · CC BY 4.0

Plaque‐adaptive flexible film dosimetry system for Ru‐106 plaque brachytherapy commissioning and quality assurance

Jin Dong Cho iD, Hojae Kim iD, Dong Wook Kim iD, Heerim Nam iD, Jin Sung Kim iD, Jung-In Kim iD

Medical Physics · 2026-03 · 53 (3)

DOI: 10.1002/mp.70286 ↗

At a glance

Journal article in Medical Physics, published online on 2026-03-10. Written by Jin Dong Cho and 5 co-authors. Institution: Department of Radiation Oncology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Major MEDLINE topics: Brachytherapy, Ruthenium Radioisotopes, Film Dosimetry, Quality Assurance, Health Care. 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministry of Trade, Industry and Energy, Korea Institute for Advancement of Technology.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Ruthenium‐106 (Ru‐106) plaque brachytherapy is an established treatment modality for choroidal melanoma that delivers localized beta radiation while sparing surrounding ocular structures. It is widely used in Europe and parts of Asia, whereas COMS Iodine‐125 and Palladium‐103 plaques remain the standard in the United States. However, its concave geometry presents challenges for accurate dose verification, as conventional flat dosimeters are ill‐suited for use during commissioning and quality assurance (QA).

Purpose

This study aimed to assess the feasibility and dosimetric accuracy of a plaque‐adaptive flexible film dosimeter (PFD) for planar and central axis (CAX) dose measurements in Ru‐106 plaque brachytherapy.

Methods

The PFD consisted of an active layer of lithium salt of pentacosa‐10,12‐diynoic acid (LiPCDA) enclosed between upper and lower silicone sheets. The flexible film was shaped to conform to the curvature of the Ru‐106 plaques and mounted within a dual‐layer film holder. A 3D‐printed QA tool was used for reproducible positioning. Dose measurements were performed at depths of 1 and 3 mm for CCA, COB, and CIB plaque types using a dual‐film configuration. Planar dose distributions were assessed at 33 manufacturer‐certified reference points at a 1 mm depth. CAX dose profiles were independently acquired using a microDiamond detector in a water phantom. All measurements were compared with manufacturer‐certified reference data. Calibration curves were established based on optical density and dose uncertainties were analyzed.

Results

The dose ratio between 1 and 3 mm depths measured with the PFD differed by –0.2% to 0.4% from the reference data across all plaque types. Planar dose measurements at 33 points yielded a mean difference of 3.0% ± 2.0% from reference values. In the high‐dose central region, the mean differences for CCA, COB, and CIB were 2.1% ± 0.8%, 2.1% ± 0.8%, and 2.2% ± 0.7%, respectively. CAX dose profiles measured with a microDiamond detector differed by 0.89% ± 0.58%. Total dose uncertainty ranged from 4.43% at 0.3 Gy to 4.19% at 2.4 Gy.

Conclusions

The PFD enabled accurate and high‐resolution dose measurements on the curved surfaces of Ru‐106 plaques. Both planar and CAX measurements demonstrated strong agreement with manufacturer‐certified reference data across all plaque types. This system offers a practical and reproducible solution for commissioning and QA in Ru‐106 plaque brachytherapy, supporting its clinical integration for choroidal melanoma treatment.

Subjects

MeSH terms (MEDLINE)

BrachytherapyRuthenium RadioisotopesFilm DosimetryQuality Assurance, Health CareRadiotherapy DosageQuality Control

Author keywords

eye plaque brachytherapyfilm dosimetryquality assurance

Substances

Ruthenium RadioisotopesRuthenium-106

Authors and institutions

  • Department of Radiation Oncology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Medical Physics and Biomedical Engineering Lab (MPBEL), Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Oncosoft, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.

ORCID profiles: Jin Dong Cho, Hojae Kim, Dong Wook Kim, Heerim Nam, Jin Sung Kim, Jung-In Kim

Funding

  • Ministry of Trade, Industry and Energy
  • Korea Institute for Advancement of Technology

Cite

APA

Cho, J. D., Kim, H., Kim, D. W., Nam, H., Kim, J. S., & Kim, J. I. (2026). Plaque‐adaptive flexible film dosimetry system for Ru‐106 plaque brachytherapy commissioning and quality assurance. Medical Physics, 53(3). https://doi.org/10.1002/mp.70286

Vancouver

Cho JD, Kim H, Kim DW, Nam H, Kim JS, Kim JI. Plaque‐adaptive flexible film dosimetry system for Ru‐106 plaque brachytherapy commissioning and quality assurance. Medical Physics. 2026;53(3). doi:10.1002/mp.70286

BibTeX
@article{Cho2026,
  author = {Cho, Jin Dong and Kim, Hojae and Kim, Dong Wook and Nam, Heerim and Kim, Jin Sung and Kim, Jung-In},
  title = {Plaque‐adaptive flexible film dosimetry system for Ru‐106 plaque brachytherapy commissioning and quality assurance},
  journal = {Medical Physics},
  year = {2026},
  volume = {53},
  number = {3},
  doi = {10.1002/mp.70286}
}
Start for free →